ATLANTA--(BUSINESS WIRE)--Vatica Health, a leading provider of physician-integrated risk adjustment and clinical quality solutions for health plans and risk-bearing providers, today announced that Shannon Delage, Chief Executive Officer of The Derm Group, a leading dermatology practice in New Jersey, has been appointed to its Board of Directors. Delage is joining Vatica during a time of significant growth and geographic expansion. Year-to-date, Vatica has more than doubled the number of lives it covers to 590,000 across a total of 17 states.
Prior to The Derm Group, Delage was a part of the founding team of Trellis Health, a women’s fertility studio, and previously served as Executive Vice President for IntegraMed Fertility. Delage’s diverse background also includes experience at Sotheby’s, Time Inc., WebMD, and Bain & Company. She graduated Magna Cum Laude from Harvard University with a BA and received her MBA in Healthcare Management at The Wharton School.
“We are delighted to welcome Shannon to the Board of Directors. Shannon’s deep experience in scaling high-growth healthcare organizations and her track record of success will be incredibly valuable,” said Dr. Hassan Rifaat, Vatica’s CEO. “Vatica is growing faster than ever, and we look forward to benefiting from Shannon’s insights as we continue our relentless pursuit of strong clinical results and financial performance for our clients.”
Vatica has grown significantly in recent years as payors and providers demand solutions to help navigate an increasingly complex process for compliantly submitting risk adjustment codes for value-based reimbursement. Vatica’s platform combines proprietary cloud-based technology with clinical personnel deployed at the point-of-care to drive clinically substantiated risk adjustment codes, improve quality of care, and ensure revenue integrity.
“Vatica is transforming the risk adjustment industry with its provider-centric model,” said Delage. “I look forward to working with the Vatica team to accelerate growth further and expand into new markets. Vatica truly improves patient outcomes, drives financial results, and enables the adoption of value-based care, and I am honored to join its Board of Directors.”
Existing Vatica board members include Mark Taber, Managing Partner of Great Hill Partners; Rafael Cofiño, Partner at Great Hill Partners; Craig Byrnes, Principal at Great Hill Partners; Dr. Hassan Rifaat, Chief Executive Officer of Vatica; and Steve Zuckerman, Co-Founder and Chief Strategy Officer of Vatica.
“We are thrilled Shannon is joining Vatica’s Board of Directors. Shannon is a talented executive and a strong operator with a demonstrated track record of driving transformational growth. Her experiences will be invaluable as Vatica continues to enable and accelerate the transition to value-based care,” said Mark Taber, Managing Partner at Great Hill Partners.
Delage was referred to Vatica through Break into the Boardroom (BiB), an initiative run by Oxeon Partners and Deerfield Management that promotes greater representation of female healthcare executives in the Boardroom.
About Vatica Health
Vatica Health is the leading PCP-centric risk adjustment and quality of care solution for health plans and health systems. By pairing expert clinical teams with cutting-edge, HITRUST-certified technology at the point-of-care, Vatica increases patient engagement and wellness, improves coding accuracy and completeness, identifies, and closes gaps in care, and enhances communication and collaboration between providers and health plans. The company’s unique solutions help providers, health plans, and patients achieve better outcomes, together. Vatica Health is trusted by many of the leading health plans and thousands of providers nationwide. For more information, please visit www.vaticahealth.com.
About Great Hill Partners
Great Hill Partners is a Boston-based private equity firm targeting investments of $25 million to $500 million in high-growth companies across the software, digital commerce, financial technology, healthcare, and digital infrastructure sectors. Over the past two decades, Great Hill has raised nearly $8 billion of commitments and invested in more than 75 companies, establishing an extensive track record of building long-term partnerships with entrepreneurs and providing flexible resources to help middle-market companies scale. In addition to Vatica Health, Great Hill’s portfolio of healthcare companies includes Pareto Health, PartsSource, Quantum Health, and RxBenefits. Prior healthcare investments include bswift, Passport Health Communications, PlanSource, Qualifacts, and SterilMed. For more information, please visit www.greathillpartners.com.
